BERKELEY HEIGHTS, New Jersey and RALEIGH, North Carolina, September 10 /PRNewswire/ --

Clinsys Clinical Research, Inc., a therapeutically focused clinical 
research organization, today announced the appointments of Rajagopalan 
Srinivasan, Ph.D as Vice President, Global Biostatistics and Christopher 
Gregory, Ph.D as Scientific Affairs-Director.

"I am excited to have Drs. Srinivasan and Gregory, both highly
experienced professionals in their respective fields in clinical research,
join the Clinsys team," said David E. Williams, Chief Executive Officer of
Clinsys Clinical Research. Mr. Williams continues, "Dr. Srinivasan, who will
head up our global biostatistics service offering, brings substantial
expertise in biostatistics directly relating to our key therapeutic areas of
Oncology, Cardiovascular and CNS. Dr. Gregory, who will serve as a senior
scientific advisor for our clinical project teams, brings a wealth of direct
pharmaceutical research development and academic experience to support our
global regulatory and scientific affairs services."

Dr. Srinivasan has over 25 years of experience in biostatistics with
regulated drug industry and medical research, including 10 years working at
the FDA. He has held a number of senior management positions in the drug
development industry, most recently as Vice President, Global Biostatistics
with a global clinical research organization. During his tenure at the FDA,
Dr. Srinivasan provided statistical guidance to regulated industry in each
step of drug development (Pre-IND, IND, End of Phase II, pre-NDA, NDA as well
as post-marketing Phase IV commitments). Dr. Srinivasan has taught
Biostatistics/Statistics at the George Washington University, Washington, DC
and is currently an adjunct Professor of Biostatistics at University of
Virginia, Charlottesville, Virginia. He received his B. Sc. (Honors), M.A.
and M. Phil degrees in Statistics from the University of Madras in India, his
Masters in Biostatistics from Florida State University, Tallahassee, Florida
and his Doctorate in Biostatistics from the University of Georgia, Athens,
Georgia.

Dr. Gregory has over 15 years of biotechnology/pharmaceutical and
academic experience. Prior to joining Clinsys, he served as Vice President,
Research for Voyager Pharmaceutical Corporation in Raleigh, North Carolina.
While at Voyager, he was responsible for directing all internal research
programs and advising on external programs as they related to indications in
CNS and Oncology, provided management of their laboratory and scientific
teams, provided guidance in product development and participated in authoring
patent applications as an inventor. Dr. Gregory was a Research Assistant
Professor in The Laboratories for Reproductive Biology; Research Assistant
Professor in the Department of Surgery, Division of Urology; Assistant
Professor and currently serves as Adjunct Assistant Professor in the
Department of Pathology and Laboratory Medicine at the University of North
Carolina at Chapel Hill, North Carolina. He earned his Doctorate in Anatomy
at Ohio State University in Columbus, Ohio and a Bachelor of Science Degree
in Biology at Concord College in Athens, West Virginia.

"We continue to strive to provide our sponsors with the most complete
service offering and the most qualified professional team in the industry,
with our primary goal of ensuring the successful completion of their clinical
development programs. Therapeutic expertise combined with a complete
understanding of the drug development process from both the CRO and sponsor
perspective, coupled with the highest level of service and quality is
absolutely essential in attaining that goal. The addition of Drs. Srinivasan
and Gregory to our high performance team will ensure that success," said Mr.
Williams.

About Clinsys Clinical Research, Inc.

Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical
research organization and a Jubilant Organosys company, headquartered in
Berkeley Heights, New Jersey. Clinsys has operations in Raleigh, North
Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Gent, Belgium;
Noida and Bangalore, India. Clinsys provides pharmaceutical and biotechnology
companies a broad range of clinical research services in support of Phase I -
IV drug development: project management, medical and clinical monitoring,
investigator and patient recruitment, site management, biostatistics, data
management, drug safety, quality assurance, regulatory affairs and medical
writing services. Clinsys has expertise in a wide range of highly specialized
therapeutic areas including oncology, cardiovascular, central nervous system,
dermatology, respiratory, and allergy/immunology. Clinsys Clinical Research,
Ltd., located in Noida, India, provides extensive clinical research services
for Phase I - IV drug development, and operates a clinical pharmacology unit
which performs bioavailability and bioequivalence studies as well as
bioanalytical sample analysis, clinical laboratory and pathology services.
Targeted Clinical Staffing Solutions(TM) (TCSS - gotcss.com), a division of
Clinsys Clinical Research, Inc., is a provider of professional staffing
solutions and innovative partnering programs for the life sciences industry.
For more information visit clinsyscro.com.

About Jubilant Organosys, Ltd.

Jubilant Organosys is an integrated pharmaceutical services provider, one
of the largest custom research and manufacturing services (CRAMS), drug
discovery and development services companies headquartered in India. Jubilant
Organosys has more than 4,300 employees across organizations in India, the
United States, Europe and China. It has four manufacturing locations in India
and two in the United States. For more information visit jubl.com.

Clinsys Clinical Research and Targeted Clinical Staffing Solutions are
registered trademarks of Clinsys Clinical Research, Inc.

Contact: Colin Coffua - Vice President, Global Marketing
    +1-908-464-7500
    ccoffua@clinsyscro.com


    Web site: http://www.clinsyscro.com
              http://www.jubl.com
              http://www.gotcss.com